Toll-like receptor 2 and 3 (TLR2/3), which abundantly expressed on human and murine DCs 22, are PRRs that recognize lipopolysaccharide and lipopeptide, and agonists of them are widely used as adjuvants in cancer vaccines. The gene discussed is TLR2; the disease is cancer.